Comparison of orlistat treatment and placebo in obese type 2 diabetic patients

Orlistat-Associated Adverse Effects and Drug Interactions

(2009) Theodosios D Filippatos et al.   DRUG SAFETY

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

(2009) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome

(2008) L. W. Cho et al.   CLINICAL ENDOCRINOLOGY

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

(2008) E. S. Nakou et al.   CURRENT MEDICAL RESEARCH AND OPINION

Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study

(2008) Erik L Madsen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

(2008) Stephen A. Harrison et al.   HEPATOLOGY

Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance

(2008) A. N. Dixon et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE